Circulating CD3+CD8+ T Lymphocytes as Indicators of Disease Status in Patients With Early Breast Cancer

Circulating CD3+CD8+ T Lymphocytes as Indicators of Disease Status in Patients With Early Breast Cancer

Abstract Background Identifying breast cancer markers with superior sensitivity, cost‐effectiveness, and practicality is imperative. Circulating immune cells and plasma cytokines hold promise as potential breast cancer markers. Aims To search and validate subtype of circulating immune cells and plas...

Full description

Saved in:

Bibliographic Details
Main Authors:	Han‐Kun Chen, Yi‐Ling Chen, Wei‐Pang Chung, Zhu‐Jun Loh, Kuo‐Ting Lee, Hui‐Ping Hsu
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Cancer Medicine
Subjects:	biomarker breast cancer CCL2 circulating immune cells cytotoxic T lymphocytes
Online Access:	https://doi.org/10.1002/cam4.70547
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
by: Sarah Talamantes, et al.
Published: (2020-10-01)

Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer
by: Eunkyung Han, et al.
Published: (2024-12-01)

New T-lymphocyte subpopulations and their characteristics: Challenges to the classical division of lymphocyte function
by: Filip Lewandowski, et al.
Published: (2024-11-01)

Assessing the causal relationships between circulating metabolic biomarkers and breast cancer by using mendelian randomization
by: Bowen Wang, et al.
Published: (2024-12-01)

The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+ and CD8+) on Chemotherapy Response in Colorectal Cancer Patients
by: Lukman K, et al.
Published: (2025-01-01)

AI-based tumor-infiltrating lymphocyte scoring system for assessing HCC prognosis in patients undergoing liver resection
by: Zhiyang Chen, et al.
Published: (2025-02-01)

Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis
by: Shuyi Niu, et al.
Published: (2025-01-01)

Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3+CD8+CD56+ Natural Killer T Population in Women with Recurrent Spontaneous Abortion
by: Fatemeh Rezayat, et al.
Published: (2023-07-01)

The CD4/CD8 ratio is associated with T lymphocyte functions in long-term virally suppressed patients with HIV
by: Qing Xiao, et al.
Published: (2025-01-01)

CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts
by: Anaïs Jiménez-Reinoso, et al.
Published: (2024-12-01)

Modeling the interaction of cytotoxic T lymphocytes and influenzavirus infected epithelial cells
by: Abdessamad Tridane, et al.
Published: (2009-12-01)

CD8+ T cell exhaustion in the tumor microenvironment of breast cancer
by: Hanghang Xie, et al.
Published: (2024-12-01)

The characterization of CD8+ T-cell responses in COVID-19
by: Yuanting Yang, et al.
Published: (2024-12-01)

Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: a case-control study in China
by: Duanchong Zhao, et al.
Published: (2024-12-01)

Predictive value of circulating lymphocyte subsets and inflammatory indexes for neoadjuvant chemoradiotherapy response in rectal mucinous adenocarcinoma patients: A machine learning approach
by: Yu Lin, et al.
Published: (2024-07-01)

Impact of Neutrophil-to-Lymphocyte Ratio on Stroke Severity and Clinical Outcome in Anterior Circulation Large Vessel Occlusion Stroke
by: Zülfikar Memiş, et al.
Published: (2024-12-01)

c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer
by: Jieun Park, et al.
Published: (2024-01-01)

Infant respiratory infections modulate lymphocyte homing to breast milk
by: Yingying Zheng, et al.
Published: (2025-01-01)

Concordance of HER2 status between primary tumor and circulating tumor cells in breast cancer
by: Peipei Xie, et al.
Published: (2024-12-01)

CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigens
by: Sara W. Feigelson, et al.
Published: (2025-02-01)

CD3+CD8+CD28− T Lymphocytes in Patients with Lupus Nephritis
by: Marcelina Żabińska, et al.
Published: (2016-01-01)

Advancing breast cancer circulating tumour cell research at the Institute of Oncology Ljubljana
by: Tanja Jesenko, et al.
Published: (2024-12-01)

PLATELET TO LYMPHOCYTE RATIO IN NEONATES: A PREDICTOR OF EARLY ONSET NEONATAL SEPSIS
by: Birol Karabulut, et al.
Published: (2019-08-01)

The trend of Epstein-Barr virus DNA loads and CD8+ T lymphocyte numbers can predict the prognosis of pediatric liver transplant recipients with PTLD
by: Wang Kedi, et al.
Published: (2025-02-01)

The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis
by: Xue Gu, et al.
Published: (2024-12-01)

Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site
by: Maria Paula Roberti, et al.
Published: (2025-12-01)

Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer
by: Qin Fang, et al.
Published: (2025-01-01)

Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker
by: Umay Kiraz, et al.
Published: (2025-01-01)

Circulating memory T cells and TCF1+ T cells aid in diagnosis and monitor disease activity in vitiligo
by: Xinju Wang, et al.
Published: (2024-11-01)

Interferon-γ production in response to the cytotoxic T lymphocyte epitope within an antigen incorporated in simian virus 40 virus-like particles
by: Takeharu Watanabe, et al.
Published: (2025-01-01)

SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma
by: Pengzhou Kong, et al.
Published: (2025-01-01)

Modelling the human immune response mechanisms to mycobacterium tuberculosis infection in the lungs
by: Gesham Magombedze, et al.
Published: (2006-07-01)

Comparison of Standard and Point-of-Care CD4+ T Lymphocyte Measurement Methods in HIV-1 Infected Turkish Patients
by: Müge Toygar Deniz, et al.
Published: (2024-12-01)

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells
by: Hongjie Wang, et al.
Published: (2024-12-01)

Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
by: Jieun Lee, et al.
Published: (2017-03-01)

Magnetic precision: Unleashing the therapeutic potential of paclitaxel-loaded nanoparticles in breast cancer treatment
by: N. Shobhana, et al.
Published: (2024-06-01)

Endosulfan promotes cell growth, migration and invasion via CCL5/CCR5 axis in MCF-7 cells
by: Zeming Liu, et al.
Published: (2024-12-01)

Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomas
by: D. Yu. Gvaldin, et al.
Published: (2024-06-01)

Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio
by: Jing Yu, et al.
Published: (2024-12-01)

Enhancement of Human Immunodeficiency Virus-Specific CD8<sup>+</sup> T Cell Responses with TIGIT Blockade Involves Trogocytosis
by: Nazanin Ghasemi, et al.
Published: (2024-12-01)